Skip to content

Evaluating the Effectiveness of AI-Driven Digital Doctors in Managing Chronic Eye Diseases

Evaluating the Effectiveness of AI-Driven Digital Doctors in Managing Chronic Eye Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098526
Enrollment
Unknown
Registered
2025-03-10
Start date
2025-03-15
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic eye diseases: such as myopia, dry eye, glaucoma, etc

Interventions

Group A:Phase 1 Digital Doctor System
the second stage is an information query system based on search engines
The third stage is the text-based question and answer system
Group B:The first stage of the textual question and answer system
the second phase of the digital doctor system
The third stage is based on the information query system of search engines
Group C:The first stage is an information query system based on search engines
the second stage of the textual question and answer system
The third stage of the digital doctor system

Sponsors

Renji Hospital, Medical College of Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) 12 to 65 years old, regardless of gender; 2) Patients with myopia (9D00.0), glaucoma (9C61) or dry eye disease (9A79) who meet any of the following ICD-11 diagnostic criteria, and have a history of face-to-face visits in the past; 3) Proficiency in the use of smart devices (e.g., smartphones, tablets, or computers) and the ability to understand and use the language used in the study. If necessary, family members need to participate in the use of the system, and the subjects and their guardians can comply with the relevant regulations of the trial, and the compliance is high; 4) The patient's chronic eye disease was in a stable state, and there was no acute exacerbation or acute intervention within half a year. and the willingness of patients and their families to actively participate in the self-management of chronic ophthalmic diseases; 5) Subjectively cooperate and be able to sign a written informed consent form. A signed and dated informed consent form by the patient or by a guardian indicates that the patient has been informed of all relevant information about the study.

Exclusion criteria

Exclusion criteria: 1) Patients with current acute ophthalmic diseases or those requiring emergency treatment; 2) Presence of other systemic diseases or serious health problems that may affect the eye, such as severe heart disease, uncontrolled diabetes, etc.; 3) Patients with cognitive impairment or psychiatric disorders that affect the understanding and use of digital systems, patients who are unable to use smart devices for daily interactions; 4) Current participation in other clinical trials or studies that may affect the results of this study; 5) Pregnant or lactating females; 6) Patients who are unwilling or unable to comply with study requirements and procedures.

Design outcomes

Primary

MeasureTime frame
Satisfaction with Patient Experience;

Secondary

MeasureTime frame
Effectiveness of Patient Health Self-management and Health Knowledge Improvement;

Countries

China

Contacts

Public ContactBilian Ke

Renji Hospital, Medical College of Shanghai Jiao Tong University

kebilian@126.com+86 133 8625 9873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026